Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 6 Ovarian Neoplasms 3 Lung Neoplasms 3 Hereditary Sensory and Autonomic Neuropathies 3 Neoplasm Metastasis 2 Fallopian Tube Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Metastatic Bladder Urothelial Carcinoma 1 Leiomyosarcoma 1 HRD Cancer 1 Colorectal Neoplasms 1 Clinical Stage III Gastric Cancer AJCC v8 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1 Brain Neoplasms 1 Advanced Solid Tumor 1

Interventions

Ifosfamide 30 Methotrexate 29 Doxorubicin 26 Cyclophosphamide 24 Cisplatin 22 Filgrastim 18 Etoposide 17 Gemcitabine 16 Leucovorin 14 Magnetic Resonance Spectroscopy 11 Temozolomide 10 Specimen Handling 10 cabozantinib 9 apatinib 9 X-Rays 9 Carboplatin 9 fludarabine 8 Radiotherapy 8 Nivolumab 8 Neoadjuvant Therapy 8 Irinotecan 8 Granulocyte Colony-Stimulating Factor 8 Drug Therapy 8 Docetaxel 8 Zoledronic Acid 7 Vincristine 7 Sirolimus 7 Phantoms, Imaging 7 Biopsy 7 mifamurtide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × berzosertib × Clear all

NCT03718091 2023-07-07

M6620 (VX-970) in Selected Solid Tumors

Massachusetts General Hospital

Phase 2 Completed

30 enrolled 15 charts

Leiomyosarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡